R. Levistre et al., INCREASE OF BRADYKININ-STIMULATED ARACHIDONIC-ACID RELEASE IN A DELTA-F508 CYSTIC-FIBROSIS EPITHELIAL-CELL LINE, Biochimica et biophysica acta, 1181(3), 1993, pp. 233-239
Modification of chloride conductance by bradykinin in epithelial cells
has been attributed to an activation of protein kinase A resulting fr
om adenylcyclase stimulation by arachidonic acid cyclooxygenase produc
ts. The results presented here compare tracheal epithelial cell lines
from one control and two cystic fibrosis patients which were immortali
zed by transfection with the SV40 large T oncogene. The three cell lin
es presented the same arachidonic acid content, turnover and mobilisat
ion under basal conditions. Bradykinin stimulated the release of arach
idonic acid and the synthesis of cyclooxygenase derivatives (mainly PG
E2). The cell line from the cystic fibrosis patient bearing a phenylal
anine 508 deletion, which is the major form of the disease, showed a h
igher bradykinin-induced arachidonic acid release than either control
cells or cells from a patient presenting a minor form of the disease.
This higher sensitivity suggests a dysregulation of phospholipase A2 s
timulation in cystic fibrosis cells and was confirmed on non-immortali
zed tracheal epithelial cells in primary culture and on skin fibroblas
ts from patients bearing the same mutation. This defect is associated
with a potentiation of cholera toxin pretreatment on cAMP content of D
ELTAF508 cell line. The impaired control of arachidonic acid release c
annot be attributed to an increased number of bradykinin binding sites
, since this increase was similar in the two cystic fibrosis cell line
s.